The ICCR wishes to extend our thanks and appreciation to Professor James Kench for his service as ICCR President for the past two years.

Professor Kench has been a significant contributor to the work of the ICCR for many years. Professor Kench’s contributions as President, Councillor and Board member has been paramount to the success of the ICCR. Professor James Kench was appointed by the World Health Organization (WHO) International Agency for Research on Cancer (IARC) to represent the ICCR on the WHO Classification of Tumours Standing editorial committee in November 2023. Professor Kench is a member of the ICCR Honorary Advisory Panel. He also co-Chaired the recent updates to the ICCR Prostate datasets and was a member of the ICCR Carcinoma of the exocrine pancreas Dataset Authoring Committee. Professor Kench is currently the ICCR representative on the ICCR Neuroendocrine tumours dataset.

Professor Kench has been actively involved in structured reporting initiatives since 2008, including as lead author for the Australian national pathology guidelines on prostate cancer, Chair of the Australian National Structured Pathology Reporting Project (2014-2018), and as a member of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) Scientific Advisory Committee, the Australian Upper Gastrointestinal Cancer Registry Steering Committee and its Hepatobiliary Subcommittee, and the NSW Cancer Council Prostate and Colorectal Cancer Expert Advisory Panels. Professor Kench has published over 200 peer-reviewed journal articles plus several books and book chapters, including co-authorship of the Prostate Cancer chapter in the 2022 WHO Blue Book for Urinary and Male Genital Tumours.

We would like to express our sincere gratitude for the significant contributions Professor Kench has made to the work of the ICCR as President. We look forward to his continued involvement in the ICCR as a Councillor and Board member.